TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Department of Agriculture (USDA) has granted conditional approval for a ...

The U.S. Department of Agriculture has given a conditional approval to Zoetis to use its bird flu vaccine in poultry, the ...

Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...

Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...

Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...

Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...

Phibro Animal Health projects strong 2025 revenue growth despite debt concerns. Read this artile to know why I think PAHC ...

Q4 2024 Earnings Call Feb 13, 2025, 8:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants.

Shares of Zoetis (NYSE: ZTS), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up ...

Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than 150 ...

A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An ...

BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...